The Keap1/Nrf2 pathway is critical for antioxidant responses and cellular defense mechanisms, contributing significantly to tumor progression and resistance to chemotherapy and radiotherapy in different cancer types (67, 68). The gene discussed is NFE2L2; the disease is cancer.